https://rjrindex.com/articles/a-pilot-randomized-controlled-trial-of-photobiomodulation-therapy-in-head-and-neck-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-aspirin-for-chemoprevention-in-lynch-syndrome-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-the-eortc-item-library-to-develop-a-tailored-patient-reported-outcome-measure-prom-cscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strengthening-multidisciplinary-collaboration-to-enhance-early-stage-melanoma-outcomes-a-quality-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-tissue-analysis-and-correlation-of-microenvironmental-changes-with-combined-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncolytic-virus-vg161-in-combination-with-camrelizumab-as-second-line-therapy-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determaio-kit-decentralizing-classification-of-the-tumor-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-as-a-front-line-therapy-for-patients-with-msi-h-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-markers-associated-with-survival-in-pd-l1-high-non-small-cell-lung-cancer-treated-with-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-sociodemographic-factors-on-thyroid-cancer-trends-in-the-united-states-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myopathic-syndromes-and-immune-checkpoint-inhibitors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-skin-integrated-melanoma-organoids-to-study-the-tumor-microenvironment-mediated-mecha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-solid-tumor-therapy-with-cd5-deleted-dsg2-directed-car-t-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-evidence-based-nsclc-testing-and-treatment-across-academic-and-community-based-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-cutaneous-toxicity-from-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-clinical-outcomes-and-healthcare-resource-utilization-in-non-hodgkins-lymphoma-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-urothelial-cancer-screening-outcomes-among-patients-with-lynch-syndrome-at-rural-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-definitive-surgery-or-radiotherapy-after-neoadjuvant-immunochemotherapy-in-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-combined-with-fruquintinib-in-patients-with-her2-expressing-or-her2-mutationampli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-efficacy-and-safety-of-anlotinib-in-postoperative-non-pcr-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-sun-safety-and-melanoma-prevention-in-the-community-through-a-multi-component-community-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-transvaginal-natural-orifice-endoscopic-surgery-v-notes-for-colon-cancer-a-prospective-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-institution-experience-using-bevacizumab-for-iidh12i-mutant-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-pivotal-trial-of-microbubble-enhanced-transcranial-focused-ultrasound-mb-fus-for-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-or-upfront-brain-radiotherapy-in-treatment-naive-lung-cancer-patients-with-asymptomatic-or-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-for-patients-pts-with-rr-chronic-lymphocytic-leukemia-cllsmall-lymphocy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-somatic-whole-exome-sequencing-and-germline-genotyping-of-dpyd-to-screen-for-dpd-defi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-ehr-interventions-to-increase-genetic-testing-for-breast-and-ovarian-cancer-predispositio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-germline-landscape-of-endometrial-cancer-focus-on-early-onset-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-prognostic-factors-in-breast-cancer-patients-with-leptomeningeal-metastasis-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-and-clinical-trends-in-common-hematological-malignancies-in-arkansas-arkansas-centr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-safety-and-efficacy-of-palbociclib-in-hr-positive-her-2-negative-mbc-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-toxicities-among-patients-receiving-regorafenib-or-trifluridinetipiracil-for-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-study-of-lnp7457-prmt5-inhibitor-in-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-lurbinectedin-in-extensive-stage-small-cell-lung-cancer-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adrb2-driven-immunosuppression-as-a-novel-prognostic-indicator-and-therapeutic-avenue-following-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acolbifene-vs-tamoxifen-for-breast-cancer-prevention-in-premenopausal-women-at-high-risk-for-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-transcription-factor-sox30-in-triple-negative-breast-cancer-metastasis-and-tumor-immune-micr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-immunophenotypic-landscape-of-early-stage-pulmonary-carcinoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-technologies-and-metastatic-colorectal-cancer-experience-and-future-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-genetic-variants-and-immunotherapy-combined-modality-with-neoadjuvant-therapy-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-chemotherapy-with-or-without-intravesical-bcg-in-nmibc-patients-a-bayesian-net 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-olutasidenib-and-azacitidine-in-patients-with-iidh1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/splicing-factor-3b-subunit-1a-sf3b1-mutations-in-lymphoid-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-artificial-intelligence-in-predicting-recurrence-after-surgical-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-in-gallbladder-cancer-incidence-mortality-and-survival-disparities-the-impact-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-label-single-arm-single-center-phase-1b2-clinical-study-of-fruquintinib-combined-with-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-veterans-diagnosed-with-chronic-myeloid-leukemia-in-the-tyrosine-kinase-inhibitor-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employer-sponsored-insurance-paid-sick-leave-and-financial-toxicity-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-circulating-tumor-dna-the-best-surveillance-tool-for-detecting-post-adjuvant-relapse-in-stage-i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-ctdna-testing-in-breast-cancer-and-its-connection-to-stress-and-anxiety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fianlimab-anti-lag-3-plus-cemiplimab-anti-pd-1-versus-cemiplimab-plus-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-among-gastric-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-mortality-risk-among-esophageal-cancer-patients-with-varied-hiv-status-seeking-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-pap-derived-ctdna-for-detection-of-sporadic-and-lynch-associated-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-detection-and-tracking-of-circulating-tumor-dna-ctdna-and-association-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-using-talimogene-laherparepvec-nivolumab-and-trabectedin-for-advanced-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-characterization-of-antibody-drug-conjugate-target-expression-profiles-in-transcriptio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-adverse-event-profiles-for-car-t-cell-therapies-and-bispecific-antibodies-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-hidden-risk-the-prevalence-of-humoral-immunodeficiency-in-patients-with-lymphoproliferati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-antibody-drug-conjugate-adc-sequential-use-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-disitamab-vedotin-rc48-for-patients-with-her2-expressing-high-risk-non-muscle-invasiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-interim-analysis-of-cabonen-an-international-multicenter-phase-ii-trial-investigating-caboz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12a-multicenter-first-in-human-open-label-clinical-trial-evaluating-mdx2001-a-tetraspec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-income-and-rurality-in-us-cancer-mortality-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-phase-2b-study-of-the-bet-bromodomain-inhibitor-beti-zen-3694-plus-enzal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-asciminib-in-combination-with-dasatinib-prednisone-and-blinatumomab-for-ph-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-efficacy-and-safety-study-of-hb0025-a-pd-l1vegf-bispecific-antibody-in-combination-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-open-label-trial-to-determine-the-optimal-duration-of-steroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-and-statistical-prediction-of-overall-survival-os-from-pre-dose-plasma-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osteoradionecrosis-as-a-complication-following-intensity-modulated-radiation-therapy-or-proton-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-and-concerns-of-the-hematology-and-oncology-hemonc-workforce-about-artificial-intellige 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ongoing-phase-12-trial-of-the-hematopoietic-progenitor-kinase-1-hpk1-inhibitor-ndi-101150-as-mono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-evaluating-the-combination-of-tg4001-an-hpv16-therapeutic-vaccine-and-av 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-landscape-of-immunotherapy-treatment-and-advanced-disease-in-head-and-neck-squamous-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analyses-of-immune-reconstitution-biomarkers-from-a-ph1b-study-of-an-investigational-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-biosimilar-entry-in-the-market-for-biologic-cancer-drugs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-anti-angiogenic-chemoradiotherapy-with-pd-1-monoclonal-antibody-for-chinese-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-selumetinib-in-adults-with-neurofibromatosis-type-1-nf1-and-symptomatic-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-socioeconomic-disparities-in-cancer-outcomes-insights-from-a-federally-qualified-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ivosidenib-and-vorasidenib-on-2-hydroxyglutarate-levels-in-low-grade-glioma-an-in-vivo-mr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-adjuvant-treatment-for-intrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observationaltranslational-study-to-conduct-real-world-evidence-and-develop-biomarkers-of-fruqui 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-survival-outcomes-in-women-with-endometrial-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-open-label-single-arm-phase-i-study-with-dose-expansion-cohort-of-sacituzumab-gov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tagitanlimab-versus-placebo-in-combination-with-gemcitabine-and-cisplatin-as-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-pathologic-response-after-neoadjuvant-therapy-and-survival-first-results-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-novel-mdm2-inhibitor-alrizomadlin-apg-115-with-or-without-toripalimab-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-3-study-of-ivonescimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-on-gbm-agile-a-global-phase-23-adaptive-platform-trial-to-evaluate-multiple-regimens-in-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-plus-bevacizumab-in-combination-with-platinum-based-chemotherapy-for-ovarian-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-signatera-genome-assay-in-a-cohort-of-patients-pts-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-from-the-phase-12-monumental-1-study-of-talquetamab-a-gprc5dcd3-bispecific-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-ivosidenib-vs-placebo-in-locally-advanced-or-metastatic-idh1-mutant-conventional-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glofitamab-plus-gemcitabine-and-oxaliplatin-glofit-gemox-in-patients-pts-with-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-perioperative-chemotherapy-versus-neoadjuvant-chemoradiation-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-multi-center-study-of-carfilzomib-lenalidomide-and-dexamethasone-krd-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-enlight-an-ai-predictor-of-immune-checkpoint-blockade-icb-response-and-resistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-adjuvant-atezolizumab-in-non-small-cell-lung-cancer-patients-in-chin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-the-recommended-phase-2-dose-rp2d-of-dose-intense-irinotecan-combined-with-iva-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-22-safety-and-efficacy-evaluation-of-nadofaragene-firadenovec-alone-or-in-combination-with-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/e7386-study-102-global-dose-expansion-cohort-of-e7386-lenvatinib-len-in-patients-pts-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/il-15rafc-superagonist-shr-1501-with-or-without-bacille-calmette-guerin-bcg-for-high-risk-non-musc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fire-4-aio-krk-0114-randomized-study-evaluating-the-efficacy-of-cetuximab-re-challenge-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-wildfire-dominated-pm-sub25sub-exposure-and-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd123-expression-and-its-correlation-with-mutation-profile-in-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activate-a-pilot-randomized-activity-coaching-trial-to-increase-vitality-and-energy-during-post-ope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-disparities-in-early-onset-squamous-cell-carcinoma-of-the-cervix-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-cancer-in-chile-27-year-mortality-rate-trends-from-a-nationwide-database-with-focus-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-data-claims-based-review-of-car-t-procedures-time-to-adverse-events-patient-character 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-pilot-study-of-neoadjuvant-chemotherapy-combined-with-immunotherapy-in-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-versus-radiologist-interpretation-in-predicting-treatment-response-in-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-oncologists-and-patients-perspectives-on-the-post-car-t-care-transition-a-convergent-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-of-health-on-mortality-in-diffuse-large-b-cell-lymphoma-dlbcl-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-disseminated-intravascular-coagulation-in-pancreatic-cancer-patients-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-neoadjuvant-and-surgical-treatment-for-locally-advanced-cervical-cancer-a-network-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-ethnic-sex-and-subspecialty-demographic-composition-of-initial-fellow-of-the-fellow-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-torc12-inhibitor-onatasertib-combined-with-toripalimab-in-patients-with-advanced-cervical-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-social-media-for-cancer-prevention-and-early-detection-challenges-opportunities-and-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-ovarian-cancer-patients-in-the-post-poly-adp-ribose-polymerase-inhibitor-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-lymph-node-dissection-on-the-prognosis-of-patients-with-intrahepatic-cholangiocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-pathologic-response-irpr-features-and-immunotherapeuticresponse-score-itrs-to-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-location-of-death-among-adolescents-and-young-adults-with-solid-and-liquid-tumors-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-regorafenib-combined-with-immune-checkpoint-inhibitors-in-advanced-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-determinants-in-nodular-sclerosis-hodgkins-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-in-vitro-fertilization-on-malignant-transformation-of-endometriotic-cysts-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-organoid-based-precision-therapy-study-in-pancreatic-cancer-adopt-a-phase-ii-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-plus-donafenib-with-or-without-anti-pd-1-antibodies-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-death-thrombotic-and-hemorrhagic-events-in-anticoagulated-patients-with-atrial-fibrillatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tace-combined-with-lenvatinib-and-pd-1-inhibitor-in-intermediate-stage-hcc-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-alcohol-use-and-liver-cell-carcinoma-related-mortality-in-the-us-a-24-yea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathognomonic-genetic-signatures-of-gallbladder-cancer-results-of-ongoing-prospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-single-cell-sequencing-to-identify-endothelial-expression-of-immune-checkpoint-ligands-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-post-ovarian-cancer-in-germline-non-brca-homologous-recombination-hr-gene-pathogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-mri-in-the-detection-of-pathological-complete-response-post-neoadjuvant-therapy-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-racial-and-ethnic-disparities-in-early-onset-versus-average-onset-gastrointestinal-cancers-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-disitamab-vedotin-rc48-in-pretreated-her2-positive-advanced-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-anti-pd-1-antibody-combined-with-chidamide-an-oral-subtype-selective-hdaci-followed-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-burden-and-trend-of-cancer-attributable-to-smoking-in-southeast-asia-east-asia-and-ocean 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-analysis-of-primary-malignant-brain-tumors-radiotherapy-in-a-low-resourced-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-spatial-transcriptomics-based-heterogeneity-of-tme-in-early-stage-invasive-pulmonary-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-technically-resectable-stage-iii-non-small-cell-lung-cancer-treated-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-on-atezolizumab-versus-placebo-in-adjuvant-therapy-of-pleural-mesothelioma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-and-appalachian-comparison-of-axicabtagene-ciloleucel-and-lisocabtagene-maraleucel-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-outcomes-from-cres-sup3sup-t-s-1-plus-cisplatin-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-autonomic-dysfunction-on-function-toxicity-and-survival-in-patients-with-lymphoma-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/better-together-synergy-of-germline-and-somatic-testing-in-hrr-pathway-driven-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/memantine-in-radiation-induced-cognitive-dysfunction-in-brain-metastases-a-double-blinded-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-polycythemia-vera-related-mortality-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-liver-malignancies-in-jordan-a-mena-region-insight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cancer-burden-in-pakistan-a-30-year-analysis-from-the-global-burden-of-disease-study-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engaging-community-to-co-design-multilevel-intervention-to-reduce-lung-cancer-disparities-in-persist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-evaluation-of-mismatch-repair-mmr-genes-in-breast-cancer-patients-missing-lynch-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-a-novel-multiplex-imaging-based-immunotherapy-panel-and-ai-powered-analysis-solution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-analysis-on-pretreatment-mri-to-predict-response-to-atezolizumab-plus-bevacizumab-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-end-of-life-care-among-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-palliative-care-access-in-patients-with-brain-metastases-a-comprehensive-national-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itx-0121-a-therapeutic-strategy-for-transcription-coupled-repair-deficient-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-cell-free-dna-cfdna-as-a-biomarker-in-pancreatico-biliary-malignancies-a-longitudin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pbmc-and-machine-learning-based-biomarker-signature-to-predict-second-line-chemotherapy-success-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-recist-11-training-program-for-improving-performance-of-contract-research-organizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-praidict-ebc-a-deep-learning-solution-for-predicting-pathological-complete-response-on-biopsi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-incidence-of-pancreatic-cancer-among-adults-aged-70-and-older-across-204-nations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parenting-challenges-of-international-medical-graduate-hematologists-oncologists-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-attitudes-and-beliefs-toward-crying-with-patients-and-its-correlation-with-burnout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-patterns-in-renal-cancer-mortality-a-20-year-analysis-of-us-mexico-border-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-results-of-intravesical-perfusion-therapy-combined-with-immediate-or-non-immediate-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-evaluation-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-related-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-reflections-on-the-horse-trial-hyperthermic-intraperitoneal-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomised-study-to-evaluate-the-antitumour-activity-of-roginolisib-a-novel-non-atp-comp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-use-disorder-among-females-with-breast-cancer-a-comprehensive-analysis-of-prevalence-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-validation-of-hypoxia-and-energy-metabolism-related-gene-signatures-in-lung-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-bcma-in-relapsed-and-refractory-multiple-myeloma-a-systematic-review-and-meta-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-concurrent-chemotherapy-in-and-out-of-a-phase-iii-randomized-controlled-trial-for-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-and-survival-evaluation-in-treating-high-risk-braf-v600-mutation-stage-iii-or-iv-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-open-label-dose-expansion-cohort-of-the-tolerability-of-tolododekin-alfa-ank-101-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rc48-adc-in-triple-negative-breast-cancer-subtypes-fuscc-tnbc-umbrella-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-targeted-enzymatic-methylation-based-early-detection-test-by-different-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-autoimmune-reactivity-in-neurotoxicities-n-tox-in-melanoma-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immune-checkpoint-inhibition-in-advanced-incurable-radioidine-refractory-differentiated-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-fixed-dose-cyclophosphamide-and-capecitabine-combination-a-novel-therapeutic-approach-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-for-disease-detection-and-monitoring-in-head-and-neck-cancer-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-toxicity-profile-with-cellular-immunotherapy-from-india-cellular-insights-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-expressional-deregulations-of-micro-rnas-and-their-potential-role-as-molecular-biomark 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tqb2930-a-her2-targeted-bispecific-antibody-combined-with-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limited-changes-in-the-cns-immune-microenvironment-in-patients-with-breast-cancer-metastasis-and-cap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-use-of-g-csf-in-non-small-cell-lung-cancer-nsclc-secondary-data-analysis-from-the-frenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-decision-support-tool-dst-in-breast-cancer-automated-national-comprehensive-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-dynamic-analysis-of-serial-ctdna-testing-to-enhance-diagnostic-and-prognostic-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-zilovertamab-vedotin-in-pediatric-and-young-adult-hematologic-malignancies-or-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-assembled-patient-derived-tumor-like-cell-clusters-for-personalized-drug-testing-in-diverse-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-pediatric-formulation-of-asciminib-in-children-with-chronic-myeloid-leukemia-in-chronic-phase-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-malnutrition-on-cardiovascular-outcomes-in-malignant-melanoma-patients-treated-with-pembr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-aso-based-jak2-inhibitor-for-the-treatment-of-hematological-malignancies-with-jak2-v617f-m-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitamin-d-serum-level-as-a-predictor-of-response-to-immunotherapy-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-derived-extracellular-vesicles-a-potential-novel-liquid-biomarker-for-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-with-programmed-cell-death-1programmed-cell-death-ligand-1-inhibitors-for-kaposi-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avidity-engineered-multifunctional-antibodies-for-stimulation-and-orchestration-of-innate-and-adapti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dihydropyrimidine-dehydrogenase-dpd-deficiency-related-variants-among-mexican-patients-with-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-radiation-pneumonitis-and-drug-induced-pneumonitis-in-patients-with-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-remote-patient-monitoring-system-by-electronic-patient-reported-outcomes-epros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-tumor-immune-microenvironment-in-gastric-cancer-patients-with-peritoneal-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-and-targeted-therapy-use-in-lung-cancer-across-state-medicaid-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effective-cancer-care-the-role-of-oncology-biosimilars-in-generating-cost-savings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-flot-vs-eox-regimen-and-non-metastatic-gastric-carcinoma-survival-outcomes-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/esophageal-squamous-cell-carcinoma-mortality-to-incidence-ratio-mir-and-survival-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disability-adjusted-life-years-dalys-and-mortality-rates-in-gastric-cancer-among-elderly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcomes-of-immune-checkpoint-inhibitor-ici-rechallenge-after-ici-pneumonitis-a-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/why-the-duration-of-cancer-treatment-requires-a-closer-look-an-empirical-analysis-of-recent-fda-app 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-first-line-immunochemotherapy-in-advanced-gastricgastroesophageal-junction-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-or-without-dna-repair-pathway-alterations-by-treatment-type-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-domestic-abuse-in-cancer-care-developing-and-piloting-a-specialized-intervention-for-hea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparative-study-of-hypertension-htn-and-time-to-treatment-failure-ttf-with-acalab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-capecitabine-plus-oxaliplatin-capox-vs-paclitaxel-plus-carboplatin-pc-as-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-a-multidisciplinary-tumor-board-and-chatgpt-40-in-the-management-of-genitourina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metanova-a-phase-ii-trial-of-metastasis-directed-radiotherapy-for-de-novo-oligometastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-among-patients-with-advanced-nsclc-treated-with-amivantam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-early-and-late-recurrence-across-breast-cancer-subtypes-in-the-cctgma32-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-care-direct-pathologist-patient-interactions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-oncology-collaborative-tumor-board-using-multiple-artificial-intelligence-agents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-dre-voided-urine-genomic-assay-to-diagnose-prostate-cancer-and-to-assess-its-aggressiveness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-model-to-forecast-patient-availability-for-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-efficacy-of-sup68sup-ga-psma-petct-scan-as-a-single-staging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disaggregating-asian-american-and-pacific-islander-subgroups-to-evaluate-disparities-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-antiresorptive-bone-agents-in-hormone-sensitive-metastatic-prostate-cancer-mhspc-a-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-early-mortality-in-acute-promyelocytic-leukemia-patients-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-flt3-inhibitors-on-the-outcomes-of-flt3-itd-positive-acute-myeloid-leukemia-following-allo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-and-docetaxel-combination-therapy-versus-nivolumab-monotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-immunotherapy-use-in-dmmrmsi-h-metastatic-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-treatment-adherence-and-unmet-needs-of-older-breast-cancer-survival-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifts-in-medicare-spending-for-patients-with-cancer-undergoing-chemotherapy-following-implementatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-recurrence-patterns-in-hispanic-vs-non-hispanic-patients-with-leiomyos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-optimal-choice-and-combination-strategy-of-vascular-targeting-therapy-for-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-three-arm-parallel-group-phase-1-study-to-assess-the-pharmacokinetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-methylation-based-tissue-free-test-for-the-detection-of-molecular-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pricing-availability-and-affordability-of-cancer-medicines-in-5-middle-income-countries-in-south-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-modelling-to-inform-pricing-for-lmics-of-immune-checkpoint-inhibitors-in-advanced-pd-l1-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-and-clinicopathological-characteristics-for-patients-with-gastric-cancer-in-a-refere 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mytx-011-a-cmet-targeting-antibody-drug-conjugate-adc-in-patients-with-previously-treated-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-an-electronic-patient-reported-outcomes-epro-based-symptom-management-program-esym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/v-rules-real-world-effectiveness-and-safety-of-cpx-351-in-patients-with-secondary-acute-myeloid-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-black-versus-non-hispanic-white-women-with-stage-iv-breast-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-oncology-terminology-using-large-language-models-for-patient-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-personalized-ai-identified-tcr-transduced-t-cell-therapy-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-relatlimab-rela-specific-biology-biomarker-analyses-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rational-use-of-adjuvant-anti-pd-1-multi-omics-model-of-recurrence-in-stage-iii-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-living-systematic-literature-review-l-slr-for-non-small-cell-lung-nsclc-prostate-pc-and-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-cv-event-risk-in-patients-pts-with-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-ai-cancer-assessment-risk-estimation-using-artificial-intelligence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-from-neoavax-a-neoadjuvant-trial-of-avelumabaxitinib-in-patients-pts-with-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-a-first-in-human-phase-1-study-of-ly4170156-an-adc-targeting-folate-receptor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-12-study-of-7mw3711-a-novel-b7-h3-antibody-drug-conjugate-adc-incorporating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-site-pattern-as-predictor-of-outcome-of-first-line-alternating-oxaliplatin-based-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-disparities-in-rectal-cancer-survival-a-retrospective-cohort-analysis-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-adults-with-kmt2a-r-acute-myeloid-leukemia-treated-with-venetoclax-plus-azacitidine-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-the-phase-3-dreamm-10-study-belantamab-mafodotin-plus-lenalidomide-and-dexamethasone-brd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multiregional-randomized-controlled-open-label-phase-3-study-of-the-anti-claudin182-cldn182 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cancer-leptomeningeal-metastasis-with-allogeneic-chimeric-antigen-receptor-ghd-t-cell-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibody-therapy-in-central-nervous-system-cns-multiple-myeloma-mm-multicenter-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-and-addressing-barriers-to-germline-testing-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-circulating-tumor-rna-ctrna-in-a-combined-circulating-tumor-dna-ctdna-and-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-dynamics-and-prognostic-significance-in-the-treatment-of-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tocilizumab-prophylaxis-for-outpatient-administration-of-teclistamab-in-relapsedrefractory-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-optimization-of-pf-07248144-a-first-in-class-kat6-inhibitor-in-patients-pts-with-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/9mw2821-a-novel-nectin-4-antibody-drug-conjugate-adc-combined-with-toripalimab-in-treatment-naiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-the-diet-study-a-randomized-controlled-phase-2-trial-of-a-high-fiber-diet-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-the-ezh2-inhibitor-tr115-in-patients-with-relapsedrefractory-non-hodgkins-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-transhepatic-arterial-infusion-chemotherapy-haic-with-folfox-regime-plus-cadonilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-durvalumab-d-chemotherapy-ct-novel-anticancer-agents-and-adjuvant-d-novel-agen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-of-stages-ii-iii-nsclc-patients-pts-who-initiate-neoadjuvant-chemo-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcome-of-pulmonary-hypertension-in-myelofibrosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-adherence-to-cancer-care-for-socioeconomically-disadvantaged-patients-with-central-nervous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membrane-specific-her2-expression-by-artificial-intelligence-based-quantitative-scoring-for-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetic-characteristics-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bat8008-a-trop-2-antibody-drug-conjugate-adc-in-patients-with-advanced-solid-tumor-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-incidence-of-obesity-related-cancer-in-adults-with-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-cancer-in-the-united-states-a-comparison-of-three-data-sources 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-oncotype-dx-o-dx-testing-and-chemotherapy-ct-use-among-patients-with-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-hmpl-306-an-inhibitor-of-mutant-idh1idh2-midh12-in-western-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-dysgeusia-related-factors-in-head-and-neck-cancer-patients-undergoing-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-potent-and-selective-inhibitors-targeting-flt3-for-aml-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pegylated-liposomal-doxorubicin-in-advanced-anthracycline-pre-treated-liposarcoma-patients-report 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-genetic-susceptibility-for-severe-cardiac-events-in-testicular-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-multidimensional-worry-in-survivors-of-early-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-of-published-randomized-phase-3-cancer-trials-to-principles-proposed-by-common-sense-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gender-gap-in-cancer-care-at-a-resident-led-federally-qualified-health-center-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complex-interplay-between-housing-insecurity-and-forgone-care-among-us-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bilateral-mastectomy-and-breast-cancer-mortality-for-invasive-lobular-carcinoma-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-h3k18-lactylation-in-cancer-associated-fibroblasts-on-malignant-pleural-effusion-progressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-low-dose-nivolumab-combined-with-chemotherapy-as-neoadjuvant-treatment-for-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-mortality-among-older-adults-with-chronic-lower-respiratory-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-nivolumab-for-patients-with-meningiomas-refractory-to-surgery-and-radiotherapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-surveillance-circulating-tumor-dna-and-merkel-polyomavirus-antibody-titer-for-detectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-insights-into-primary-sarcoma-tissues-using-a-novel-approach-of-ex-vivo-functional-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-histone-demethylation-to-knock-down-ihoxa-as2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-predictors-of-survival-in-non-surgical-management-of-malignant-bowel-obstruction-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-trends-of-mucinous-small-bowel-adenocarcinoma-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-for-patients-with-advanced-and-metastatic-pancreatic-cancer-treated-with-sacituz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-specific-trends-in-incidence-and-prevalence-of-pancreatic-cancer-a-global-burden-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-insights-liquid-ngs-in-community-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-palliative-care-needs-of-early-phase-clinical-trial-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-with-anlotinib-and-chemotherapy-for-second-line-treatment-of-pancreatic-ductal-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-mutations-in-dna-damage-repair-genes-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-and-early-stage-clinical-study-on-the-regulation-of-tumor-associated-inflammatory-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-clinical-utility-and-microsatellite-instability-detection-on-the-marsden360-ctdna-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-treatment-ctdna-dynamics-to-predict-response-to-chemotherapy-in-patients-with-metastatic-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-multi-center-phase-ii-study-of-utidelone-injection-in-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-metastatic-burden-in-shaping-mortality-trends-in-patients-with-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-signatures-and-clinical-outcomes-in-patients-with-thymic-epithelial-tumors-and-good-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-trilaciclib-versus-granulocyte-colony-stimulating-factor-regarding-chemotherapy-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-and-clinical-impact-of-influenza-virus-infection-in-hospitalized-lung-cancer-patients-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-18f16a-fluoro-17v-fluoroestradiol-fes-pet-in-predicting-response-to-endocrine-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-complete-blood-count-model-for-colorectal-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathological-differences-in-colorectal-cancer-rectum-left-colon-and-microsatellite-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetics-and-family-history-in-a-diverse-cohort-of-females-with-early-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-lost-evidence-a-phase-iii-multicenter-randomized-controlled-trial-of-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-top-10-italian-priorities-in-renal-cell-carcinoma-rcc-a-people-centered-approach-to-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pde5-inhibitor-use-on-survival-outcomes-in-male-predominant-cancers-a-propensity-score-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-neoadjuvant-therapy-regimens-and-prediction-of-immune-effects-for-her2-positive-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-mediated-resistance-mechanisms-in-nat-treated-her2-positive-breast-cancer-bc-a-single-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-1021-gene-ngs-panel-for-hrd-detection-in-clinical-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-epidemiology-of-gallbladder-cancer-gbc-real-world-clinical-characteristics-and-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-selfie-study-cervical-precancer-detection-using-novel-human-papillomavirus-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-cancer-distribution-and-survival-outcomes-among-adolescent-and-young-adult-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-ibrca1-i-ibrca2-i-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-polygenic-risk-score-for-breast-cancer-in-chinese-women-a-three-stage-case-control 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-cytomegalovirus-infection-among-patients-receiving-chimeric-antigen-receptor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-population-based-screening-for-6-gene-panel-testing-for-hereditary-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-survival-of-central-nervous-system-tumors-in-a-population-based-cancer-regis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-for-cancer-risk-stratification-a-bi-directional-approach-to-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-declining-renal-function-on-bladder-cancer-bc-mortality-in-the-us-1999-2023-a-regre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-systemic-therapy-in-breast-cancer-with-cns-metastases-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-rates-of-liver-and-intrahepatic-bile-duct-cancers-in-young-hispanic-populations-an-explor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-analysis-to-predict-response-to-immune-checkpoint-blockade-icb-in-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-genomic-characteristics-and-outcomes-among-patients-with-metastatic-lobular-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-treatment-modalities-and-overall-survival-in-microsatellite-stable-and-unstable-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-mitoxantrone-hydrochloride-liposome-in-relapsed-and-refractory-pediatric-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-embolism-outcomes-across-five-cancer-types-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-patterns-of-cell-surface-marker-expression-in-clinically-relevant-subgroups-of-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-patients-pts-with-hr-negative-her2-low-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-serplulimab-with-dp-induction-chemotherapy-followed-by-nimotuzumab-and-imrt-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-using-gemcitabine-and-cisplatin-followed-by-hypofractionated-radiotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-colorectal-cancer-screening-programme-based-on-bisulfite-free-sequencing-of-methylated-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mesenchymal-stem-cell-therapy-in-radiation-induced-xerostomia-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-active-cancer-on-mortality-and-complications-after-tavr-a-systematic-review-and-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnosis-and-follow-up-of-immune-related-hypophysitis-with-mri-of-pituitary-gland 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-durvalumab-plus-chemotherapy-with-or-without-oleclumab-for-locally-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/macroscale-genomic-alterations-in-histomolecular-invasive-lobular-carcinoma-compared-to-other-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-risk-prediction-model-in-her2-positive-early-breast-cancer-after-her2-targeted-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychological-interventions-for-anxiety-in-older-patients-with-lung-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-trials-landscape-in-follicular-lymphoma-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-from-hepatocellular-carcinoma-associated-with-non-alcoholic-fatty-liver-disease-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-stereotactic-body-radiotherapy-for-cervical-cancer-score-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-design-of-novel-parp-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-volve-phase-ii-clinical-trial-in-women-with-ovarian-cancer-progressing-post-parp-inhibitor-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-effectiveness-in-unresectable-hepatocellular-carcinoma-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-safety-and-efficacy-of-small-versus-medium-size-particles-in-drug-eluting-bead-chemoem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-and-treatment-patterns-among-cholangiocarcinoma-patients-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-culturally-appropriate-non-opioid-pain-coping-skills-training-intervention-for-spanish 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-co-occurring-kras-and-gain-of-function-tp53-mutations-with-aggressive-metastasis-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tumor-microenvironment-in-cholangiocarcinoma-impact-of-natural-killer-cells-on-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-burden-and-financial-toxicity-in-cancer-patients-a-sub-analysis-from-a-brazilian-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-donafenib-versus-bevacizumab-in-combination-with-immune-checkpoin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-acceptance-of-scalp-cooling-in-patients-receiving-chemotherapy-for-primary-gynecologic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-infusion-sepsis-protocol-and-outcomes-for-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-black-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-inp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-clinical-trial-navigation-program-for-cancer-patients-barriers-and-facilitators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexuality-and-age-functioning-and-quality-of-life-qol-in-prostate-cancer-pc-patients-after-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesenchymal-stromal-cells-for-the-prophylaxis-of-graft-versus-host-disease-after-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-decision-making-in-follow-up-care-for-lung-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-embolism-in-cancer-patients-clinical-insights-and-outcomes-from-a-community-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/google-search-analysis-what-do-people-want-to-know-about-prostate-cancer-and-where-do-they-find-ans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-cancer-patients-in-senegal-a-cross-sectional-study-in-two-care-facilities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disparities-in-trends-of-medicare-reimbursements-and-service-volumes-for-stereotactic-radio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-combined-with-chidamide-and-letrozole-as-neoadjuvant-therapy-for-hr-positive-her2-negat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-ras-family-gene-mutations-in-metastatic-solid-tumors-in-venezuela-experience-at-a-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-photon-and-proton-radiotherapy-populations-in-pediatric-patients-a-single-institutional-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-tp53-mutation-status-and-initial-disease-burden-at-presentation-to-risk-stratify-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-overall-survival-with-abiraterone-acetate-compared-to-enzalutamide-in-patients-with-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-clinical-predictors-of-30-day-readmissions-in-aml-patients-undergoing-allogeneic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-on-treatment-on-rx-tumor-volume-reduction-tvr-to-predict-response-to-the-keynote-522-kn-5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-collaborative-care-based-symptom-intervention-model-on-chemotherapy-adherence-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-usefulness-of-an-immune-related-adverse-events-interview-application 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-natural-language-processing-nlp-approach-for-optical-character-recognition-ocr-resilient-extra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficiency-and-quality-of-clinical-summaries-produced-by-a-large-language-model-llm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/target-therapy-adoption-for-myelodysplastic-syndromes-mds-and-acute-myeloid-leukemia-aml-a-five 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-associated-with-distress-thermometer-dt-screening-among-patients-with-cancer-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-current-programmed-death-ligand-1-pd-l1-testing-practices-for-metastatic-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kaleido-registry-a-multi-center-registry-platform-with-site-staff-and-automation-to-enable-accelera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-in-gastric-cancer-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-as-prognostic-biomarkers-in-advanced-gastric-cancer-treated-with-cdc25b-phos-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-radiation-therapy-contribute-to-breast-cancer-related-lymphedema-after-axillary-node-dissection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-breast-cancer-hub-initiative-conducting-door-to-door-cervical-cancer-awareness-symptom-identific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-psma-heterogeneity-and-alternative-targets-expression-in-psma-negative-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-in-patients-with-myelofibrosis-and-platelets-50-x10-sup9sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-imetelstat-in-myelofibrosis-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-outcomes-and-the-healthcare-burden-in-esophageal-cancer-patients-with-atrial-fibrilla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-myeloproliferative-neoplasms-related-mortality-in-the-united-states-over-the-last 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-metastatic-breast-cancer-mbc-diagnosis-in-structured-electronic-health-record-ehr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptional-profiling-to-identify-a-program-of-enzalutamide-extreme-non-response-in-lethal-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/underreporting-of-health-related-quality-of-life-in-trials-of-matched-targeted-therapies-for-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-related-myeloid-neoplasms-a-seer-database-analysis-of-residential-distribution-on-overall-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-35-does-a-tool-designed-to-measure-potentially-preventable-chemotherapy-toxicities-do-so-effecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-stromal-targeting-antitumor-car-t-cells-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-to-predict-the-efficacy-and-prognosis-of-immunotherapy-for-extensive-stage-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospitalization-patterns-in-metastatic-melanoma-patients-with-and-without-sepsis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-between-breast-cancer-and-coronary-artery-disease-insights-from-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nemtabrutinib-in-relapsed-or-refractory-chronic-lymphocytic-leukemiasmall-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-xenografts-pdx-versus-patient-derived-organoids-pdo-as-predictors-of-clinical-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fasting-if-during-pd-1-checkpoint-blockade-a-pilot-safety-and-feasibility-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-dose-escalation-study-of-av-380-anti-gdf15-monoclonal-antibody-in-combination-with-stan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-trastuzumab-deruxtecan-and-radiation-therapy-in-her2-positive-and-her2-low-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-glp-1-receptor-agonists-on-outcomes-in-metastatic-renal-cell-carcinoma-patients-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-extrachromosomal-dna-ecdna-on-imycni-amplified-neuroblastom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-adjuvant-treatment-in-resected-stage-iii-cutaneous-melanoma-patients-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-development-and-validation-of-a-simulation-model-based-calculation-engine-to-support-individuali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-distamab-vedotin-combined-with-carboplatin-and-bevacizumab-for-her2-expressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-icotinib-of-12-months-versus-observation-as-adjuvant-therapy-for-completely-resected-egfr-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-to-predict-docetaxel-benefit-for-high-risk-localized-prostate-cancer-in-nrg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-neoadjuvant-penpulimab-combined-with-chemotherapy-for-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-with-surufatinib-camrelizumab-nab-paclitaxel-and-s-1-in-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-giant-cell-tumor-of-bone-a-case-series-in-the-denosumab-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-fact-inhibitor-cbl0137-in-pediatric-patients-with-relapsed-or-refractory-soli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-circulating-tumor-dna-ctdna-for-disease-recurrence-or-relapse-in-melanoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-treatment-outcomes-in-stage-iv-endometrial-carcinoma-a-13-year-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-radiotherapy-plus-immunotherapy-and-influence-on-prognosis-in-driver-gene-negative-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-release-syndrome-among-acute-lymphocytic-leukemia-adults-undergoing-treatment-with-blinatum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-colorectal-cancer-and-its-attributable-risk-factors-in-latin-america-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metscreen-decision-support-tool-for-metastatic-colorectal-cancer-patients-based-on-organoid-drug-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ensartinib-as-postoperative-adjuvant-therapy-in-patients-with-alk-positive-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geriatric-assessment-and-management-with-a-question-prompt-list-using-a-web-based-application-to-red 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-i-wish-i-had-known-a-pediatric-oncologists-transition-to-survivorship-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-evaluation-of-tev-56278-a-pd-1-targeted-attenuated-il-2-molecule-in-a-human-ex-vivo-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-antitumor-activity-data-from-a-phase-1-study-of-incb123667-a-selective-cdk2-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-oncolytic-adenovirus-biottt001-in-patients-with-peritoneal-carcinomatosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-anti-trop2-antibody-drug-conjugate-adc-ibi130-in-patients-pts-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-time-trial-phase-ii-randomized-controlled-trial-of-time-of-day-specified-immunotherapy-for-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-anti-pd-1ctla-4-bispecific-antibody-plus-chemotherapy-in-early-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-for-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-clinical-genomic-and-transcriptomic-characterization-of-circulating-kim-1-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-asciminib-asc-in-patients-pts-with-chronic-phase-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-low-do-you-need-to-go-association-between-various-prostate-specific-antigen-psa-response-meas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-clinical-and-molecular-analysis-of-the-eortc-randomized-phase-iii-intergroup-catnon-trial-on-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-differences-in-lung-cancer-mortality-trends-across-the-united-states-us-rural-urb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-1-study-of-ep0031-a-next-generation-selective-ret-inhibitor-sri-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seizure-related-homolog-6-sez6-expression-and-ctdna-methylation-profiles-in-patients-with-high-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-socioeconomic-status-on-access-to-next-generation-sequencing-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-standard-vs-reduced-dosing-of-sotorasib-on-efficacy-and-toxicity-in-kras-g12c-mutated-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-patients-pts-with-previously-treated-locally-advanced-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pivotal-studies-of-pharmacotherapies-approved-by-the-united-states-food-and-drug-administration-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-from-the-phase-2-study-of-timdarpacept-in-combination-with-tisle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-detected-tumor-infiltrating-lymphocytes-and-response-to-pd-1-based-treatment-in-advanced-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologics-in-the-treatment-of-immune-related-adverse-events-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-pan-cancer-molecular-residual-disease-assessment-using-whole-genome-sequencing-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-accuracy-and-concordance-of-pathologists-and-the-utility-of-ai-assistance-software-for-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vebreltinib-plus-plb1004-in-egfr-mutated-nsclc-with-acquired-met-amplification-or-overexpression-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-in-the-phase-3-trial-of-cabozantinib-vs-placebo-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-fu-naliri-gemcitabine-plus-nab-paclitaxel-or-both-regimens-given-sequentially-for-first-line-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-liver-tumor-segmentation-a-comprehensive-meta-analysis-of-deep-learning-approaches 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-zanubrutinib-zanu-versus-fixed-duration-acalabrutinib-plus-venetoclax-av 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-outcomes-of-an-outpatient-lymphoma-bispecific-antibody-program-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-symptoms-in-children-treated-with-chimeric-antigen-receptor-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-medicare-recipients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-combined-therapy-with-pemetrexed-and-carboplatin-in-progressive-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bacterial-glycosyltransferases-on-resistance-to-lewis-y-targeting-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-platinum-sensitive-recurrent-ovarian-cancer-treated-with-prolonged-parp-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-hipec-response-in-ovarian-cancer-with-pi3krasnotch-gene-signatures-a-whole-transcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-patient-reported-outcomes-in-hospitalized-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-gip-and-glp-1-receptor-agonists-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histologic-comparison-of-the-area-of-tumor-bed-after-vacuum-assisted-biopsy-vab-or-standard-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-medical-mistrust-mm-to-medical-decision-making-mdm-preferences-in-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-l-and-randomized-phase-ll-trial-of-radium-223-dichloride-peposertib-and-avelumab-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacist-led-medication-reconciliation-televisit-mrt-for-phase-1-oncology-clinical-trials-a-tel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suboptimal-suppression-of-serum-androgen-levels-among-men-treated-with-apalutamide-and-abiraterone-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-virtual-reality-supportive-care-intervention-bmt-vr-for-patients-undergoing-hematopoietic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-colorectal-cancer-screening-rates-in-veterans-a-quality-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-implications-of-using-truncated-medicare-definitions-of-avoidable-hospital-visits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-trial-of-preoperative-pembrolizumab-and-chemotherapy-followed-by-adjuvant-pembrol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-the-science-of-cancer-in-latinos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-zero-passage-ex-vivosingle-cell-mass-response-assay-to-predict-tumor-response-an-observational-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-and-neck-cancers-in-southeast-asia-2022-incidence-and-mortality-estimates-for-2022-and-project 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-stage-ii-iva-esophageal-and-esophagogastric-cancers-treated-with-multimodal-therapy-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-care-of-older-adults-with-cancer-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/training-an-alternate-oncology-workforce-attendee-feedback 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unexplored-targets-in-myeloid-neoplasms-investigating-potential-areas-of-clinical-actionability-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-ibrcai-mutations-in-breast-cancer-shedding-light-on-radiation-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-prolonged-hospital-length-of-stay-following-craniotomy-for-brain-tumor-resection-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-iberdomide-and-dexamethasone-kid-in-patients-with-transplant-eligible-newly-diagnose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/case-study-is-there-any-impact-of-insurance-type-on-disposition-outcomes-in-cancer-patients-on-comf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-treatment-of-patients-with-ros1-positive-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-in-tki-naive-patients-with-advanced-alk-positive-non-small-cell-lung-cancer-nsclc-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-for-progression-during-adaptive-androgen-deprivation-therapy-for-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-cell-free-dna-testing-as-a-predictor-for-relapse-post-allogeneic-stem-cell-transpla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-medication-adherence-and-testosterone-suppression-in-patients-with-prostate-cancer-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raced-reduction-of-cervical-cancer-disparities-the-impact-of-navigators-and-racial-literacy-train 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-simplified-scoring-system-to-predict-in-hospital-mortality-of-leukapheresis-in-patients-with-leuke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-correlation-of-two-snps-in-the-drachmotif-with-gefitinib-induced-hepatotoxicity-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-monotherapy-for-melanoma-or-non-small-cell-lung-cancer-in-india-results-of-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicopathologic-analysis-and-management-approaches-for-metaplastic-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitors-versus-pd-l1-inhibitors-in-pd-l1-negative-advanced-non-small-cell-lung-cancer-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-imaging-workflow-with-ai-integration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-early-identification-model-for-oncology-case-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-analysis-of-characteristics-and-risk-of-recurrence-ror-in-black-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-racial-and-socioeconomic-disparities-on-radiation-therapy-delays-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-female-breast-cancer-among-adolescent-and-young-adults-in-southeast-asia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-urinary-morbidity-in-men-undergoing-combination-prostate-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-hematopoietic-stem-cell-transplant-patients-with-hematologic-malignancies-accou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-incorporating-apps-on-enrollment-and-engagement-in-nci-trials-at-an-ncorp-site 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-a-two-protein-panel-pms2msh6-for-detecting-mismatch-repair-deficiency-in-endo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetismm-30-a-phase-1b-open-label-study-of-elranatamab-in-combination-with-iberdomide-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytic-and-clinical-validation-of-a-negative-prediction-algorithm-for-actionable-mutations-utilizi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-chemoradiotherapy-with-or-without-nimotuzumab-in-induction-chemotherapy-resistant-locoreg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-real-world-study-of-first-line-pd-l1-inhibitor-use-in-patients-with-metastatic-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-complex-code-of-tumor-microenvironment-and-heterogeneity-by-comparing-multiple-primar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-granulocyte-colony-stimulating-growth-factors-g-csgf-usage-in-patients-treated-with-sac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-resistance-to-anti-pd1-treatment-in-recurrent-andor-metastatic-squamous-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-pharmacokinetics-pk-of-zurletrectinib-a-next-generation-pan-trk-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-maturation-antigen-bcma-immunohistochemistry-ihc-staining-in-multiple-myeloma-mm-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yap1-and-downstream-gene-alterations-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-continuing-neoadjuvant-intent-immunotherapy-for-advanced-resectable-cutaneous-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-de-novo-stage-metastatic-head-and-neck-cancer-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-causes-of-failures-in-oral-leukoplakia-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-targeted-therapies-tt-and-immunotherapy-io-on-outcomes-in-patients-pts-with-anaplast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-aberrantly-methylated-collagen-genes-in-colorectal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sim0270-in-combination-with-palbociclib-in-patients-with-er-her2-advanced-breast-cancer-the-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-monitoring-during-cdk46-inhibitor-therapy-for-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-impact-of-covid-19-on-septicemias-healthcare-associated-complications-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-intricacies-of-illiteracy-an-indigenous-language-and-religious-beliefs-on-oncology-and-palliat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-diagnosed-with-stage-iv-cancer-in-2020-based-on-covid-19-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-trends-and-survival-outcomes-in-clinical-stage-iii-melanoma-a-real-world-analysis-of-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daily-low-dose-oral-temozolomide-as-maintenance-therapy-following-doxorubicin-plus-dacarbazine-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-temporal-trends-of-prostate-cancer-among-patients-with-acute-cardiovascular-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-al-based-models-integrating-serum-proteomics-and-clinicopathologic-features-to-predict-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-malignant-neoplasm-risk-after-mediastinal-radiotherapy-for-pediatric-hodgkin-lymphoma-on-chil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lipid-metabolic-gene-expression-and-association-with-decreased-overall-survival-and-immunogenicity-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-outcomes-in-nsclc-patients-with-concurrent-gerd-on-proton-pump-inhibitors-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-burkitt-lymphoma-related-mortality-in-the-united-states-over-the-last-three-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-geographic-hotspots-due-to-lymphoma-related-mortality-a-21-year-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-radio-chemoimmunotherapy-versus-neoadjuvant-chemoimmunotherapy-for-resectable-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-beyond-blood-harnessing-pleural-effusion-circulating-tumor-dna-for-precision-lung-cancer-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-due-to-pulmonary-embolism-in-patients-with-hematolymphoid-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-racial-disparities-in-acute-in-hospital-outcomes-of-hairy-cell-leukemia-across-the-us-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicity-with-belzutifan-in-the-treatment-of-von-hippel-lindau-disease-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-oral-tazemetostat-an-ezh2-inhibitor-in-relapsed-or-refractory-b-cell-non-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-treatment-associated-evolutionary-dynamics-in-advanced-urothelial-cancer-via-deep-whole-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-bisphosphonates-and-other-bone-modifying-agents-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serious-infections-in-patients-with-cllsll-treated-with-combination-venetoclax-and-obinutuzumab-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkertesting-in-metastatic-colorectal-cancer-mcrc-2015-2024-trends-in-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterisation-of-ductal-carcinoma-in-situ-dcis-using-mass-spectrometry-imaging-towards-near-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-pneumonitis-in-asian-patients-with-small-cell-lung-cancer-a-systematic-literature-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/picking-needles-in-a-haystack-exploring-rare-variants-of-a-pan-cancer-target-in-the-ret-landscape-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-to-assess-safety-and-preliminary-evidence-of-a-therapeutic-effect-of-azeliragon-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-predictors-of-mortality-among-patients-with-virus-associated-cancers-in-a-high-hiv-prev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncological-implications-of-hormone-replacement-therapy-in-women-with-kallmann-syndrome-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-in-combination-with-bacillus-calmette-guerin-bcg-in-bcg-naive-in-bcg-naive-high-risk-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-reliability-accuracy-and-utility-of-clinical-abstraction-methods-from-unstructured-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-immune-checkpoint-inhibitors-ici-in-hepatocellular-carcinoma-hcc-5-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tace-in-combination-with-sorafenib-versus-sorafenib-or-tace-alone-for-advanced-hepatocel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-control-trial-of-concurrent-paclitaxel-and-carboplatin-along-with-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prior-neoadjuvantadjuvant-chemotherapy-nactact-on-fruquintinib-plus-sintilimab-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-radiotherapy-combined-with-anlotinib-in-locally-advanced-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-colorectal-cancer-in-the-republic-of-ireland-trends-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-incidence-with-bireociclib-in-hrher2-advanced-breast-cancer-pooled-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-age-specific-trends-in-the-incidence-of-anorectal-cancer-associated-with-human-papillomavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-egfr-and-vegf-inhibitors-in-stage-ii-iv-colon-cancer-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-long-term-glucocorticoid-use-on-cancer-risk-in-patients-with-rheumatologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-cns-neoplasms-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-polyphenols-and-the-risk-of-prostate-cancer-in-the-prospective-southern-community-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-outcome-of-brain-metastases-in-breast-cancer-patients-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-obesityoverweight-and-its-relationship-with-incidence-of-pancreatic-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-sleep-disturbance-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qingre-huoxue-formula-and-its-key-active-components-as-associated-with-multi-targeted-effects-on-hum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-eniluracil-capecitabine-6422-cap-in-phase-1b-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cluster-analysis-of-clinician-distress-trajectories-when-caring-for-seriously-ill-hospitalized-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-adenosquamous-carcinoma-pasc-a-comparative-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-of-disitamab-vedotin-in-bladder-preservation-during-neoadjuvant-therapy-for-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-molecular-tumor-board-on-treatment-decisions-for-advanced-solid-tumors-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-camrelizumab-and-paclitaxel-liposome-and-nedaplatin-as-first-line-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-confirmatory-germline-testing-in-patients-with-somatic-brca12-pathogenic-variants-acros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-child-pugh-b-and-c-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-hepatic-arterial-infusion-chemotherapy-and-anti-pd-1-antibody-therapies-for-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eliciting-the-patient-perspective-using-design-thinking-methodology-to-assess-the-utility-of-incorp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-communication-and-satisfaction-in-breast-cancer-does-doctor-patient-identity-conco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-pain-management-knowledge-among-hospice-family-caregivers-a-randomized-controlled-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-using-metronomic-gemcitabine-doxorubicin-and-docetaxel-plus-nivolumab-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elucidating-the-epigenetic-landscape-of-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-therapy-with-donafenib-in-hepatocellular-carcinoma-with-high-risk-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-lipid-laden-kupffer-cells-in-immunosuppression-and-immunotherapy-response-in-masld-relat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-3d-telomeres-profiling-for-myeloma-mrd-and-evaluation-of-concordance-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/it-io-intrathecal-administration-of-nivolumab-and-ipilimumab-in-combination-with-systemic-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ficerafusp-alfa-with-pembrolizumab-in-patients-with-recurrent-or-metastatic-head-and-neck-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extranodal-malt-lymphoma-a-retrospective-survival-analysis-study-from-seer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-and-serum-cytokines-as-biomarkers-for-pathological-complete-response-pcr-and-recurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-outcomes-following-minimally-invasive-gastrectomy-for-gastric-cancer-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-rivoceranib-and-tace-in-the-perioperative-treatment-of-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-circulating-tumor-dna-ctdna-monitoring-in-early-stage-hrher2-invasive-lobular-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-clinical-outcomes-of-imatinib-personalized-dosing-in-gastrointestinal-stromal-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-status-prediction-in-patients-with-advanced-breast-prostate-ovarian-and-pancreatic-cancers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-autologous-chimeric-engulfment-receptor-t-cell-cer-1236-targeting-tim-4-l-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc108-in-combination-with-furmonertinib-in-patients-with-locally-advanced-or-metastatic-egfr-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-preliminary-efficacy-results-of-a-phase-1-study-of-lb2102-a-dntgfvrii-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ifupinostat-bebt-908-in-combination-with-rituximab-for-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-targeted-intra-tumoral-hyperthermia-as-an-immunotherapy-in-immunogenically-cold-tumor-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-tumor-infiltrating-lymphocytes-til-monotherapy-on-persistent-clinical-and-immunologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-radiomics-to-predict-outcome-of-neoadjuvant-chemotherapy-in-patients-with-muscle-invasive-bladde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-adi-270-an-armored-allogeneic-anti-cd70-chimeric-antigen-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-basket-trial-of-tarlatamab-in-patients-with-advanced-dll3-expressing-tumors-university-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-educated-platelets-as-a-source-of-potential-biomarkers-for-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-tim-3-blockade-tqb2618-with-penpulimab-and-chemotherapy-in-the-first-line-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-003-phase-23-trial-of-zilovertamab-vedotin-plus-standard-of-care-in-relapsedrefractory-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-lisaftoclax-apg-2575-combined-with-azacitidine-aza-in-patients-pts-with-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variation-in-communication-of-cancer-risk-in-prostate-cancer-treatment-consultations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemokines-as-predictive-biomarkers-for-immune-checkpoint-inhibitor-ici-efficacy-in-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-zggs15-a-dual-specific-antibody-targeting-lag-3-and-tigit-as-monotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-combination-of-naxitamab-with-or-without-sintilimab-anti-pd-1-for-the-treatment-of-refractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-adverse-events-with-parp-inhibitors-real-world-pharmacovigilance-study-using-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-guideline-concordant-treatment-receipt-for-localized-prostate-cancer-pca-a-seer-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo4metpanc-combination-chemotherapy-gemcitabine-and-nab-paclitaxel-chemokine-c-x-c-motif-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-ici-in-patients-pts-with-central-nervous-system-cns-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-complications-of-patients-receiving-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-dose-extension-study-of-a-next-generation-anti-cd47-monoclonal-antibody-imc-002-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-first-in-human-phase-iii-study-of-vls-1488-an-oral-kif18a-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myocarditis-in-patients-with-non-small-cell-lung-cancer-treated-with-immune-checkpoint-inhibitors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-mri-scan-position-using-a-novel-head-and-neck-immobilization-device-on-radical-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-ctdna-mutational-landscape-in-her2-positive-metastatic-breast-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcomes-and-clinicopathologic-determinants-of-response-for-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-car-t-cell-therapy-versus-standard-of-care-for-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-gene-panel-blood-test-for-the-detection-of-colorectal-adenomas-and-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-behavior-characteristics-in-breast-cancer-patients-nhanes-study-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postmarketing-safety-of-loratinib-an-analysis-of-the-fda-adverse-event-reporting-system-faers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastrointestinal-adverse-event-in-patients-with-and-without-pre-existing-inflammatory-bowel-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-omic-analysis-to-reveal-gene-regulatory-network-of-immune-landscape-in-childhood-solid-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-almb-0168-a-novel-monoclonal-antibody-activating-cx43-hemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-integrated-proactive-supportive-care-pathways-in-oncology-results-from-the-proact-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccdi-cog-molecular-characterization-initiative-the-expanding-data-on-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-change-in-cardiac-function-after-doxorubicin-and-dexrazoxane-a-report-from-cog-alte11c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-infusion-therapy-management-in-metastatic-breast-cancer-real-world-pilot-study-of-a-new-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-abo-gene-have-prognostic-value-for-immunotherapy-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-in-neoadjuvant-treatment-of-locally-advanced-differentiated-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-spinal-laser-interstitial-thermal-therapy-for-metastatic-spinal-cord 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-cabazitaxel-c-vs-lutetium-lu-177-vipivotide-tetraxetan-lu-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-with-or-without-lenvatinib-as-adjuvant-therapy-for-hcc-with-microvascular-invasion-mvi-or-por 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-quality-of-life-of-cervical-cancer-patients-and-analysis-of-clinical-data-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-instability-score-gis-and-benefit-from-olaparib-ola-and-bevacizumab-bev-maintenance-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-for-profiling-the-microenvironment-of-cervical-precancer-progression-from-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-and-prognostic-characteristics-of-gastric-type-endocervical-adenocarcinoma-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-method-for-rapid-collection-of-microgram-amounts-of-cell-free-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-adapted-tool-to-measure-health-related-social-needs-for-the-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-intensification-in-veterans-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-prevalence-and-incidence-of-pancreatic-cancer-among-adults-aged-70-and-older-a-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-hemoglobin-levels-and-cancer-risk-an-analysis-using-nhanes-2017-2020-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-mammogram-rates-across-texas-in-2022-a-statewide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-25-year-perspective-on-tongue-cancer-related-mortality-nationwide-trends-and-disparities-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-lower-respiratory-tract-neoplasms-among-older-adults-with-history-of-tobacco-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-sacituzumab-govitecan-for-the-treatment-of-patients-with-diffuse-pleural-mesothel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ddr-mutations-mt-in-idh-mutant-high-grade-gliomas-hgg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-indian-cancer-genome-landscape-pathogenic-alterations-and-emerging-therapeutic-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-soft-tissue-and-extraosseous-sarcomas-1980-2021-regional-and-economic-disparitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-plus-donafenib-and-immune-checkpoint-inhibitors-for-intermediate-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-architecture-for-deciphering-the-complexity-of-tumor-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-akt-inhibitors-on-radiation-sensitivity-oxidative-stress-emt-reversal-and-immune-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatments-for-resectable-rpc-and-borderline-resectable-pancreatic-adenocarcinoma-brp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ripretinib-versus-sunitinib-in-imatinib-resistant-gastro-intestinal-stromal-tumor-with-kit-exon-11-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-with-nalirifox-nfx-compared-to-folfirinox-ffx-in-patients-not-previously-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-survival-in-advanced-stage-high-grade-primary-peritoneal-serous-cystadenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-adjusted-indirect-comparison-paic-of-avelumab-ave-and-retifanlimab-reti-in-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pct1co-stim-tcr-t-cells-to-overcome-the-hostile-tumor-micro-environment-and-target-triple-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-and-addressing-unmet-needs-in-colorectal-cancer-findings-from-the-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-mapping-tumor-responses-to-radiotherapy-in-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-factors-enabling-to-predict-and-management-of-hypocalcemia-following-total-thyroidectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-combination-immune-checkpoint-inhibitor-therapy-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-blinded-independent-central-review-committee-and-physician-assessed-responses-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-oral-mucositis-on-nutrition-among-patients-with-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-associated-with-de-novo-metastatic-colorectal-cancer-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-multiple-myeloma-in-asian-indian-and-pakistani-americans-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-survival-outcomes-of-transoral-surgery-with-or-without-adjuvant-chemoradiotherapy-vs-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-pathologic-complete-response-in-colorectal-cancer-patients-after-immunotherapy-based-on-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adverse-events-of-ciltacabtagene-autoleucel-a-b-cell-maturation-antigen-directed-chimeri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-adjusted-time-without-symptoms-of-disease-or-toxicity-q-twist-analysis-of-pembrolizumab-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-real-time-model-for-predicting-recurrence-and-survival-in-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-tumor-microenvironment-and-pd-l1-analysis-using-digital-pathology-to-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-renal-failure-and-multiple-myeloma-related-mortality-among-adults-aged-55 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-incision-laparoscopic-surgery-vs-conventional-laparoscopic-surgery-for-colorectal-cancer-sho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-killer-cell-transcriptomic-expression-and-prediction-of-survival-after-immune-checkpoint-blo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-and-outcomes-for-older-patients-in-phase-3-clinical-trials-for-metastatic-and-unresec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-feasibility-of-a-peer-support-group-for-patients-with-cancer-presently 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-oncology-clinical-trials-by-absolute-neutrophil-count-eligibility-criteria-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-previous-cancer-history-with-the-incidence-of-prostate-cancer-harboring-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-health-communication-and-young-onset-cancer-yoc-healthcare-practitioners-attitudes-and-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-and-racial-disparities-of-chromosome-8q-gains-in-prostate-cancer-insights-from-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-financial-toxicity-in-oncology-a-comprehensive-analysis-of-prescription-cost-disparitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overuse-of-diagnostic-therapeutic-and-consultative-services-among-hospitalized-patients-approachin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-high-body-mass-index-on-acute-lymphoblastic-leukemia-a-30-year-global-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-burnout-on-oncologists-and-hematologists-inunc-agendum-esti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/usp22-as-promoter-of-treg-cell-infiltration-and-modulator-of-immunotherapy-efficacy-through-the-pias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphovascular-invasion-as-a-prognostic-factor-in-pt2-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lapnet1-phase-1b-study-investigating-the-association-of-np137-with-mfolfirinox-in-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/constructing-genetic-immune-prognostic-subtypes-of-primary-duodenal-adenocarcinoma-through-whole-exo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-differential-effect-of-stromal-genes-on-gemcitabinenab-paclitaxel-gn-and-gncisplatin-gcn-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-for-improved-treatment-response-assessment-and-prediction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-on-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u06-substudy-06e-a-phase-12-open-label-umbrella-platform-study-of-ifinatamab-deruxtecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-of-ovarian-cancer-care-since-the-introduction-of-poly-adp-ribose-polymerase-inhibitors-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-incidence-in-mongolia-a-clinical-and-molecular-pathological-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-iron-deficiency-anemia-on-long-term-cardiovascular-outcomes-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-standardized-documentation-for-goals-of-care-among-advanced-stage-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-community-academic-partnership-to-improve-clinical-trial-access-in-southern-alabama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-acceptability-of-remote-activity-and-patient-reported-outcome-monitoring-in-men-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-node-recurrence-after-sentinel-lymph-node-biopsy-for-ycn0-patients-treated-with-primary-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-olutasidenib-in-relapsedrefractory-acute-myeloid-leukemia-outcomes-by-number-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-pts-younger-than-50-years-old-yo-with-treatment-naive-blastic-plasmacytoid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-irak4-long-isoform-as-widely-upregulated-in-non-splicesome-mutated-acute-myeloid-leukemia-and-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-novel-androgen-receptor-inhibitors-in-nonmetastatic-castration-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-darolutamide-efficacy-and-safety-in-treating-non-metastatic-and-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-frailty-in-vulnerable-hematopoietic-cell-transplantation-candidates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-sup177sup-lu-nym032-for-progressive-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-acute-care-events-designing-prognostic-models-for-real-world-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-deep-learning-model-to-predict-residual-tumor-in-advanced-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-lung-cancer-screening-education-among-minoritized-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-barriers-to-colorectal-cancer-screening-and-research-enrollment-by-minoritized-and-underi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-the-reduction-in-complexity-of-ordering-dna-sequencing-tests-through-the-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flubu2-and-flumel-with-and-without-ptcy-comparative-effectiveness-and-safety-in-allogeneic-stem-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-access-in-patients-with-pancreatic-cancer-pc-a-pancreatic-cancer-action-network-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/workforce-economic-and-infrastructural-barriers-to-global-oncology-clinical-trial-participation-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-integrative-medicine-as-tailored-treatment-for-cancer-patients-a-multicentre-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-black-and-non-hispanic-white-nhw-men-with-prostate-cancer-pca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upgrade-rates-and-treatment-recommendations-for-patients-with-pleomorphic-and-florid-lobular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-patient-reported-wellness-outcomes-in-head-and-neck-cancer-patients-treated-with-proton-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-genomic-landscape-of-early-mortality-in-patients-with-stage-iv-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-and-genomic-landscape-analysis-of-gi-stromal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-in-immunomodulatory-drug-imid-sparing-regimens-for-patients-with-newly-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-site-specific-immune-related-adverse-events-of-pd-l1-blockade-in-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-hlx22-plus-trastuzumab-and-xelox-for-first-line-treatment-of-human-epidermal-grow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lymphoma-and-covid-19-among-hospitalized-cancer-patients-a-population-based-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-second-line-2l-treatment-with-tivozanib-tivo-as-monotherapy-or-with-nivolumab-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-multicentric-observational-real-world-evidence-rwe-study-on-cost-impact-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-anal-small-cell-carcinoma-a-perspective-from-the-united-states-national-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-treated-with-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/over-a-decade-of-insights-into-genomic-profiling-in-metastatic-colorectal-cancer-from-a-phase-i-sett 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-tt-00973-ms-a-highly-selective-and-potent-axl-inhibitor-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-cdk46-inhibitors-post-chemotherapy-in-hr-her2-metastatic-breast-cancer-patients-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-panel-of-four-protein-tumor-markers-for-effective-and-affordable-lung-cancer-early-detection-by-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-aptamer-based-non-invasive-test-for-lung-cancer-a-proof-of-concept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-features-of-breast-cancer-metastatic-to-gynecologic-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-prognostic-factors-in-cancer-specific-survival-for-patients-with-metastatic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-short-course-radiotherapy-followed-by-sintilimab-anlotinib-combined-with-capox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-resected-breast-cancer-brain-metastases-a-retrospective-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-tumour-bacterial-ecosystems-topological-data-analysis-of-bacterial-association-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-heroes-study-targeting-molecular-relapse-in-breast-cancer-a-secondary-adjuvant-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-analysis-and-trend-of-liver-cancer-mortality-attributable-to-drug-use-in-united-states-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-not-otherwise-specif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menopausal-hormone-therapy-after-a-diagnosis-of-breast-cancer-in-women-with-a-ibrcai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-outcomes-of-palliative-care-in-colorectal-cancer-hospitalizations-a-propensity-matched-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-germline-sequencing-and-mlpa-analysis-in-breast-cancer-patients-4-years-of-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/black-patients-with-cutaneous-t-cell-lymphoma-ctcl-and-their-likelihood-to-receive-novel-agents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-and-sociodemographic-disparities-in-moderate-or-excessive-polypharmacy-among-ol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-non-interventional-study-to-investigate-the-treatment-patterns-of-nerati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/off-label-use-of-fam-trastuzumab-deruxtecan-in-desmoplastic-small-round-cell-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blended-survivorship-and-palliative-care-for-patients-with-advanced-lung-cancer-receiving-targeted-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-profile-and-risk-factors-associated-with-incadronate-disodium-treatment-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-as-neoadjuvant-therapy-for-hr-positive-her2-low-breast-cancer-a-single-arm-phase-ii-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-bowhead-health-patient-navigator-for-breast-cancer-treatment-in-india-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-basket-trial-evaluating-the-efficacy-of-tasurgratinib-e7090-in-patients-with-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-for-post-surgical-molecular-residual-disease-in-patients-with-stage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-nivolumab-plus-ipilimumab-in-microsatellite-instability-high-metastatic-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copec-trial-early-determination-of-pathological-tumor-response-to-neoadjuvant-chemotherapy-in-lowi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-non-viral-apd1-msln-jl-lightning-car-t-in-advanced-malignant-mesothelioma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pivekimab-sunirine-pvek-in-patients-pts-with-blastic-plasmacytoid-dendrit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-treatment-and-intra-tumoral-gene-expression-and-immune-cell-changes-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-mfolfoxiri-chemotherapy-with-or-without-cadonilimab-versus-mfolfox6-alone-in-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensified-hormonal-blockade-with-sbrt-in-psma-pet-detected-oligometastatic-prostate-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10563-a-phase-i-study-of-peposertib-and-liposomal-doxorubicin-for-advanced-or-metastatic-leio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-results-of-pdl1v-pf-08046054-a-vedotin-based-adc-targeting-pd-l1-in-patients-with-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-shr-2017-a-ranklngf-targeted-antibody-in-patients-pts-with-breast-cancer-bo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-lung-cancer-clinical-characteristics-and-tumor-subtypes-using-cell-free-dna-fragmentomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-taxane-platinum-doublet-chemotherapy-with-triple-oral-metronomic-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nut-carcinoma-survival-outcomes-and-epidemiology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-analysis-for-a-phase-3-randomized-trial-comparing-afatinib-to-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-icis-in-advanced-large-cell-neuroendocrine-carcinoma-lcn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-analysis-of-modified-topaz-1-a-biweekly-regimen-of-gemcitabine-and-cisplatin-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctc-landscape-during-hcc-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/docetaxel-with-androgen-deprivation-therapy-adt-and-radiotherapy-rt-for-high-risk-localized-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-pembrolizumab-pembro-plus-chemotherapy-chemo-for-locally-advanced-gastric-or-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patritumab-deruxtecan-her3-dxd-in-active-brain-metastases-bm-from-metastatic-breast-mbc-and-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forte-a-phase-2-master-protocol-assessing-plixorafenib-for-braf-altered-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-third-line-therapies-a-comprehensive-review-of-regorafenib-versus-fruquintinib-with-plac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-outcomes-in-stage-iii-melanoma-patients-treated-with-adjuvant-immunotherapy-vs-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-bispecific-innate-cell-engager-ice-afm24-with-atezolizumab-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smet12-and-toripalimab-combined-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-wh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-evaluating-physical-functioning-and-symptoms-in-patients-with-pretre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-of-iclostridium-difficilei-colitis-infection-and-ileus-among-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-ct-declination-among-patients-with-early-stage-hormone-receptor-positive-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-proportion-score-tps-and-response-to-first-line-1l-anti-pd-1pd-l1-plus-chemotherapy-for-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avutometinibdefactinib-and-gemcitabinenab-paclitaxel-combination-in-first-line-metastatic-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-rates-of-patients-with-primary-malignant-cardiac-tumors-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-xgboost-in-predicting-outcomes-among-car-t-therapy-patients-the-impact-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-first-in-human-phase-1-dose-escalation-trial-of-adrx-0706-a-next-generat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-a-tumor-agnostic-circulating-tumor-dna-assay-for-uveal-melanoma-surveillance-and-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-clonal-hematopoiesis-frequency-following-parp-inhibitor-treatment-and-its-associati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-survival-outcomes-and-biomarker-results-of-sure-01-neoadjuvant-sacituzumab-govitecan-sg-mon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-in-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-broad-spectrum-kit-inhibitor-nb003-and-activity-in-advanced-gastrointestinal-stromal-tumors-gis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trade-off-preferences-in-older-adults-with-newly-diagnosed-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-between-survival-and-quality-of-life-and-their-association-with-clinical-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-by-neighborhood-of-association-correlates-with-car-t-referrals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-ii-trial-of-olaparib-in-combination-with-ceralasertib-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-of-catequentinib-hydrochloride-al3818-versus-placebo-in-subjects-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oligometastatic-gastrointestinal-stromal-tumor-association-between-treatment-type-metastatic-patte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptome-classification-of-pten-inactivation-to-predict-survival-benefit-from-docetaxel-at-star 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-a-large-language-model-based-system-versus-manual-review-in-clinical-data-abstraction-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-the-therapeutic-cancer-vaccine-ose2101-versus-docetaxel-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-2-investigator-initiated-etctn-trial-of-olaparib-radium-223-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-open-label-study-of-selective-axl-mer-and-csf1r-inhibitor-adrixetinib-q702-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taletrectinib-in-iros1i-non-small-cell-lung-cancer-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swognrg-s1914-randomized-phase-iii-trial-of-inductionconsolidation-atezolizumab-sbrt-versus-sbr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-two-decades-of-cancer-trends-in-adolescents-and-young-adults-insights-from-a-resource-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-serplulimab-based-therapy-in-her2-negative-advanced-gastric-cancer-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-comparing-pragmatic-interventions-to-improve-mammogram-uptake-in-a-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-single-arm-phase-ii-study-of-pemigatinib-combined-with-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-venous-thromboembolism-on-survival-in-multiple-myeloma-patients-receiving-bispecific-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-of-adoption-and-implementation-of-a-financial-navigation-program-in-nigeri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generative-ai-to-augment-the-fairness-of-foundation-models-in-cancer-pathology-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-preoperative-chemoradiotherapy-versus-chemotherapy-for-resectable-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-treatment-patterns-and-adverse-reactions-of-bevacizumab-in-the-chinese-population-in-the-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-and-validation-of-the-clavien-dindo-classification-for-oncologic-surgeries-in-a-high-volume-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choose-breath-not-death-improving-lung-cancer-screening-in-the-christus-good-shepherd-internal-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-bite-therapy-in-rural-wisconsin-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apalutamide-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-real-world-experience-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-weekly-docetaxel-regimens-in-prostate-cancer-a-systematic-review-and-network-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-germline-genetic-testing-in-advanced-prostate-cancer-survey-results-from-the-germline-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-low-dose-carboplatin-and-docetaxel-in-combination-with-toripalimab-for-early-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-prognostic-and-predictive-value-of-il-1v-trop2-and-b7-h3-in-egfr-mutated-egfrm-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-a-pre-screening-platform-for-clinical-trials-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-race-predict-adherence-to-relugolix-among-patients-with-prostate-cancer-a-veterans-health-admi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-male-and-female-breast-cancer-care-a-comparative-analysis-of-stage-at-presentation-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breath-based-voc-analysis-leveraging-canine-olfaction-for-multi-cancer-detection-insights-from-a-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-among-cancer-patients-receiving-chimeric-antigen-receptor-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-cytopenic-myelofibrosis-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-ipss-m-in-predicting-survival-and-relapse-after-allogeneic-hsct-for-mds-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigator-assisted-hypofractionation-navah-phase-i-clinical-trial-of-breast-cancer-patients-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasively-collected-buccal-cell-mrna-and-potential-for-a-novel-breast-cancer-signal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-and-gene-expression-profiles-as-predictors-of-survival-in-recurrent-high-grade-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-liver-cancer-mortality-in-the-united-states-2010-2021-a-call-for-focused-public-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-health-records-ehr-based-machine-learning-ml-approach-to-predict-risk-of-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-electrophysiologic-biomarkers-of-cognition-in-glioma-infiltrated-cortex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-survival-with-nivolumab-nivo-relatlimab-rela-vs-nivo-ipilimumab-ip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immunosuppressed-patients-with-merkel-cell-carcinoma-treated-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-molecular-characteristics-and-enhanced-efficacy-of-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-genomic-analysis-of-tumor-tissue-and-surgical-margin-distances-in-esophageal-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-use-disorder-on-outcomes-in-gastrointestinal-cancer-patients-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-placebo-controlled-trial-on-repurposing-olanzapine-for-prevention-of-radiothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-advanced-osteosarcoma-patients-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-reuse-after-failure-of-first-line-ici-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-safety-and-efficacy-of-datopotamab-deruxtecan-and-sacituzumab-govitecan-for-secon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/area-deprivation-index-and-egfr-mutated-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ehealth-disease-educational-intervention-vs-outpatient-palliative-care-as-usual-among-incurable-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-outcome-of-transarterial-chemoembolization-combined-with-immune-checkpoint-inhibitors-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-ascites-in-patients-hospitalized-with-pancreatic-cancer-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-infectious-sarcoid-like-inflammatory-granulomatous-conditions-nsigc-associated-with-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characteristics-affecting-cholangiocarcinoma-patients-with-and-without-hepatitis-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-mortality-trends-2018-2023-exposing-racial-inequities-in-michigans-cancer-burd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-safety-analysis-of-an-open-label-single-arm-phase-ii-trial-investigating-the-efficacy-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-plus-lenvatinib-and-pd-1-inhibitors-as-first-line-treatment-f-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-hematology-amp-oncology-ho-knowledge-for-internal-medicine-residents-a-dell-med-guid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-educational-and-practice-needs-of-oncology-pharmacists-in-west-africa-a-case-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neighborhood-level-factors-with-access-to-genetic-testing-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypertension-and-renal-cancer-related-mortality-patterns-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-changes-in-advanced-clear-cell-renal-cell-carcinoma-ccrcc-pre-and-post-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-oncolytic-bacteria-product-sgn1-and-its-impact-on-pd-l1-expression-cd8-t-cell-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-evidence-based-treatment-selection-and-patient-centered-care-in-upper-gi-cancers-a-projec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-multicenter-study-of-adjuvant-adebrelimab-plus-capecitabine-in-resected-chola 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-infection-on-car-t-therapy-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-supervised-prehabilitation-program-for-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ovarian-cancer-in-adolescents-and-young-adults-compared-with-older-women-prognostic-factors-demogr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-failure-and-treatment-for-hepatocellular-carcinoma-after-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-graft-versus-host-disease-on-mortality-length-of-stay-and-hospitalization-costs-in-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-outcomes-by-prior-definitive-treatment-tx-in-patients-pts-with-high-risk-biochemically 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-ecology-of-dcis-microenvironmental-drivers-of-recurrence-and-progression-to-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volume-and-acuity-trends-in-geriatric-patients-with-cancer-insights-from-a-comprehensive-cancer-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-the-asco-pga-in-a-remote-australian-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-lung-cancer-risk-in-breast-cancer-survivors-a-40-year-comprehensive-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-health-experiences-among-us-immigrant-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-access-to-care-through-sustainable-replicable-model-of-care-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-analysis-of-outcomes-following-autologous-hematopoietic-cell-transplantation-in-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-a-novel-plasma-eight-protein-signature-predicting-long-term-efficacy-of-first-line-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-evaluation-of-relapsed-pediatric-cancers-what-information-do-these-sequential-analyses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-study-of-bria-ots-cellular-immunotherapy-in-metastatic-recurrent-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-survival-outcomes-among-children-with-non-metastatic-ewing-sarcoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-in-african-american-patients-with-multiple-myeloma-the-role-of-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-implications-of-immune-related-adverse-events-after-exposure-to-vegf-inhibitors-on-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-clinical-determinants-of-survival-in-metastatic-breast-cancer-a-population-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-therapeutic-strategies-for-metastatic-triple-negative-breast-cancer-with-homologous-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-the-anti-immunoglobulin-like-transcript-3-ilt3-monoclonal-antibody-mab-mk-0482 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-parp-1-in-er-positive-endocrine-resistant-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-disparities-affecting-pharyngeal-cancer-in-the-us-a-21-year-retrospective-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-biomarker-prediction-in-oncology-enhancing-pathological-image-analysis-with-exaonepath 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testicular-function-after-immune-checkpoint-inhibitors-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-assessment-of-leiomyosarcoma-lms-and-cancers-in-the-li-fraumeni-syndrome-lfs-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-a-1021-gene-ngs-panel-for-comprehensive-tumor-profiling-in-ffpe-and-liquid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-preferred-place-of-death-for-metastatic-melanoma-patients-in-the-united-states-from-2015-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-an-optimized-tissue-agnostic-genome-wide-methylome-enrichment-assay-to-predict-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-patterns-of-melanoma-early-and-late-recurrence-after-adjuvant-anti-pd1-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemotherapy-treatment-on-immunotherapy-efficacy-in-colorectal-cancer-crc-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-real-time-model-for-predicting-survival-in-advanced-ie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-year-survival-outcomes-after-perioperative-pembrolizumab-pembro-in-patients-with-human-papilloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-efficacy-and-safety-results-of-bat1308-a-pd-1-inhibitor-chemotherapy-bevacizumab-in-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-tumor-microenvironment-composition-to-favor-pd-1-inhibition-via-pretreatment-with-low-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pretreatment-emotional-distress-and-survival-outcomes-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-radiotherapy-be-considered-for-the-initial-treatment-of-ovarian-cancer-brain-metastases-find 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-participant-data-meta-analysis-comparing-neoadjuvant-to-perioperative-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-and-cutaneous-t-cell-lymphomas-in-the-united-states-a-21-year-mortality-analysis-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-car-t-cell-therapy-product-in-the-clinical-outcome-of-patients-with-relapsedrefractory-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-histological-subtypes-in-non-muscle-invasive-utuc-propensity-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1pd-l1-inhibitors-as-neoadjuvant-therapies-in-resectable-non-small-cell-lung-cancer-including-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-identification-of-a-metabolic-gene-prognostic-signature-malmps-model-to-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-cohort-real-world-study-of-treatment-for-metastatic-colorectal-cancer-mcrc-overall-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-thymoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-driving-distance-to-clinic-with-treatment-route-and-dosing-for-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fhinch-study-fertility-and-sexual-health-effects-of-cancer-therapy-in-young-women-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-tumor-somatic-mutations-by-race-in-va-patients-with-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-plus-chidamide-in-hrher2-advanced-breast-cancer-following-cdk46-inhibitor-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-critical-appraisal-of-current-recommendations-for-lung-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recruitment-strategies-and-enrollment-for-a-virtually-supervised-exercise-intervention-for-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-nsclc-with-no-targetable-driver-mutation-among-different-races-an-exploratory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-epidemiology-and-mortality-over-12-years-socioeconomic-and-demographic-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-her2-positive-metastatic-breast-cancer-patients-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-pertuzumab-combined-with-taxanes-or-eribulin-in-her2-positive-breast-cancer-a-single-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-predictors-of-exceptional-response-exres-in-patients-pts-initiating-first-line-1l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-total-neoadjuvant-therapy-sequencing-with-surgical-intervention-and-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-the-treatment-of-stage-iibc-and-iiia-colorectal-cancer-a-national-cancer-database-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-cancer-community-outreach-and-engagement-to-explain-impact-of-age-income-residence-know 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-targeting-of-vegf-and-pd-1-a-phase-iii-trial-of-ivonescimab-a-novel-bispecific-antibody-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-of-distinct-follicular-lymphoma-histologic-grades-insights-from-genomic-and-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/astrocytoma-survival-patterns-and-key-prognostic-factors-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-metformin-exposure-on-colorectal-cancer-incidence-according-to-tumor-sidedness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-paclitaxel-and-nedaplatin-as-conversion-therapy-for-locally-advancedadva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-to-predict-outcomes-in-recurrentmetastatic-cervical-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-body-fluid-cfdna-advancing-diagnostics-and-therapeutic-decisions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/board-certification-practices-of-us-hematologists-and-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-results-from-the-kgog3056nirvana-r-trial-maintenance-niraparib-plus-bevacizumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-clinically-actionable-biomarker-detection-in-advanced-cancers-by-next-generation-sequenci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-treatment-trajectories-in-a-sample-of-cervical-cancer-patients-in-the-democratic-rep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-sup68sup-gaga-psma-11-pet-biodistribution-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-clinical-study-of-icaritin-in-combination-with-gemcitabine-and-nab-pacitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/broadening-the-gates-analysis-of-potentially-modifiable-screen-failures-in-pancreatic-and-biliary-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-racism-and-physician-trust-impressions-of-african-american-breast-cancer-patients-enrolled-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examination-of-post-radiation-survey-data-from-the-navigator-assisted-hypofractionation-navah-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ten-year-patterns-of-women-participating-in-treatment-clinical-trials-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-predictors-of-late-second-primary-malignancies-in-long-term-breast-prostate-colon-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-experience-with-an-immunotherapy-telehealth-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-reporting-and-methodological-rigor-of-non-inferiority-trials-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sorafenib-plus-hepatic-arterial-infusion-chemotherapy-versus-sorafenib-plus-transarterial-chemoembol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-cancer-care-for-undocumented-immigrants-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-somatic-homologous-recombination-deficiency-hrd-in-triple-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-effectiveness-of-trastuzumab-deruxtecan-t-dxd-in-her2-overexpressing-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-generative-model-for-the-design-of-novel-inhibitors-targeting-the-pd-1pd-l1-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2dx-prognostic-value-in-older-patients-with-her2-positive-early-breast-cancer-a-correlative-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-supportive-and-nutrition-care-program-for-older-adults-with-advanced-pancreatic-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-combined-with-pd-1-antibody-in-unresectable-colorectal-liver-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teledermatology-dermoscopy-expanding-access-to-skin-cancer-screening-to-reduce-healthcare-dispariti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-according-to-time-of-day-of-combined-immuno-chemotherapy-for-advanced-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-data-analysis-in-egfr-mutated-nsclc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-safety-and-preliminary-efficacy-of-amulirafusp-alfa-imm0306-in-combination-with-lenalidom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc044-a-phase-ii-trial-of-bezuclastinib-in-combination-with-sunitinib-in-patients-with-gist-who-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-patients-with-advanced-ireti-fus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-shr-a2102-a-nectin-4-directed-antibody-drug-conjugate-adc-in-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-colorectal-cancer-precision-medicine-through-multi-omics-and-clinical-data-integration-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-dose-finding-phase-ib-study-to-assess-the-safety-tolerability-of-nesuparib-jpi-547 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-toripalimab-plus-capeox-in-patients-with-locally-advanced-ebv-positive-gastric-or-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eaton-a-phase-i-trial-of-nazartinib-egf816-and-trametinib-in-egfr-mutant-egfrmut-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-outcomes-in-gyneco-oncology-in-late-and-last-line-setting-real-world-data-from-the-molecu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhibition-of-transcriptional-cyclin-dependent-kinases-cdk1213-as-a-treatment-for-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-imtapi-deletion-on-immunotherapy-outcomes-in-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-post-discharge-symptom-monitoring-on-hospital-readmissions-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-platinum-based-chemotherapy-bevacizumab-for-persistent-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-of-survival-and-recurrence-after-liver-transplantation-for-unresectable-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-adjuvant-cemiplimab-cemi-versus-placebo-pbo-for-high-risk-cutaneous-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-concurrent-intravenous-iv-and-intrathecal-it-nivolumab-n-and-relatlimab-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-survival-following-relapse-of-high-risk-neuroblastoma-a-study-from-the-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trofuse-020gog-3101engot-cx20-a-phase-3-randomized-active-controlled-open-label-multicenter-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-prognostic-precision-in-bladder-cancer-ai-driven-tumor-microenvironment-analysis-from-ha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-23-clinical-trial-investigating-rp2-plus-nivolumab-vs-ipilimumab-plus-nivolumab-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerance-and-preliminary-efficacy-of-autologous-tumor-infiltrating-lymphocytes-tils-lm10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-abemaciclib-a-cdk46-inhibitor-in-participants-with-hiv-associated-and-hiv-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-combined-with-camrelizumab-and-s-1-for-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-retrieval-augmented-generation-based-large-language-model-to-guide-oncologists-in-sea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pelvic-ultrasound-a-missed-opportunity-for-earlier-detection-of-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologous-tumor-infiltrating-lymphocytes-hs-it101-with-low-dose-lymphodepletion-and-il-2-infusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-plasma-cell-free-dna-methylation-based-multi-cancer-detection-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-related-adverse-events-with-survival-and-treatment-outcomes-in-thymic-tumors-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-rag-01-a-novel-small-activating-rna-therapeutic-in-bcg-failure-non-muscle-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-data-from-nexicart-2-the-first-us-trial-of-car-t-in-rr-light-chain-al-amyloi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-trial-of-adebrelimab-plus-nab-paclitaxel-and-carboplatin-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-after-luveltamab-tazevibulin-a-novel-folate-receptor-a-fra-targeting-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-timely-mental-health-care-in-cancer-patients-a-national-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-trial-of-the-androgen-receptor-ligand-directed-degrader-bms-986365-versus-investigators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-hcb101-a-novel-fc-based-anti-sirpa-cd47-fusion-protein-in-subjects-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-on-treatment-ctdna-dynamics-and-response-by-imaging-in-patients-with-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-novel-targeting-of-s100a9-with-tasquinimod-for-relapsed-and-refractory-multiple 2026-08-24 monthly 0.7